Vestcor Inc’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
SIM
GIM
BCM
Vestcor Inc's TXG Position: Q2 2022 in Review
Vestcor Inc sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 1,231 shares — an estimated $94K sold.
Vestcor Inc first reported a position in TXG in Q2 2021 and held it in 4 quarters. The position peaked at $240K in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.
- Vestcor Inc reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
- Vestcor Inc sold 1,231 10x Genomics shares in Q2 2022, an estimated $94K.
- Vestcor Inc first reported a position in 10x Genomics in Q2 2021 and held it in 4 quarters.
- Vestcor Inc's 10x Genomics position peaked at $240K in Q2 2021.
- 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.
Based on Vestcor Inc's 13F filing for Q2 2022, filed 15 Aug 2022.